Literature DB >> 27340023

Stroke: The question of alteplase dose for stroke is not resolved.

Junya Aoki1, Kazumi Kimura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27340023     DOI： 10.1038/nrneurol.2016.90

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians.

Authors:  Shigeru Ueshima; Osamu Matsuo
Journal:  Thromb Haemost       Date:  2002-03       Impact factor: 5.249

2.  Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.

Authors:  Craig S Anderson; Thompson Robinson; Richard I Lindley; Hisatomi Arima; Pablo M Lavados; Tsong-Hai Lee; Joseph P Broderick; Xiaoying Chen; Guofang Chen; Vijay K Sharma; Jong S Kim; Nguyen H Thang; Yongjun Cao; Mark W Parsons; Christopher Levi; Yining Huang; Verónica V Olavarría; Andrew M Demchuk; Philip M Bath; Geoffrey A Donnan; Sheila Martins; Octavio M Pontes-Neto; Federico Silva; Stefano Ricci; Christine Roffe; Jeyaraj Pandian; Laurent Billot; Mark Woodward; Qiang Li; Xia Wang; Jiguang Wang; John Chalmers
Journal:  N Engl J Med       Date:  2016-05-10       Impact factor: 91.245

3.  Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).

Authors:  Takenori Yamaguchi; Etsuro Mori; Kazuo Minematsu; Jyoji Nakagawara; Kazuo Hashi; Isamu Saito; Yukito Shinohara
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

4.  Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients.

Authors:  A-Ching Chao; Ching-Kuan Liu; Chih-Hung Chen; Huey-Juan Lin; Chung-Hsiang Liu; Jiann-Shing Jeng; Chaur-Jong Hu; Chih-Ping Chung; Hung-Yi Hsu; Wen-Yung Sheng; Han-Hwa Hu
Journal:  Stroke       Date:  2014-07-03       Impact factor: 7.914

5.  Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).

Authors:  Joung-Ho Rha; Vasantha Padma Shrivastava; Yongjun Wang; Kim En Lee; Niaz Ahmed; Erich Bluhmki; Karin Hermansson; Nils Wahlgren
Journal:  Int J Stroke       Date:  2012-09-18       Impact factor: 5.266

6.  Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.

Authors:  Xiaoling Liao; Yilong Wang; Yuesong Pan; Chunjuan Wang; Xingquan Zhao; David Z Wang; Chunxue Wang; Liping Liu; Yongjun Wang
Journal:  Stroke       Date:  2014-07-10       Impact factor: 7.914

7.  Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours: A Comparative Effectiveness and Safety Study.

Authors:  Beom Joon Kim; Moon-Ku Han; Tai Hwan Park; Sang-Soon Park; Kyung Bok Lee; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Jae Kwan Cha; Dae-Hyun Kim; Jun Lee; Soo Joo Lee; Youngchai Ko; Jong-Moo Park; Kyusik Kang; Yong-Jin Cho; Keun-Sik Hong; Joon-Tae Kim; Jay Chol Choi; Dong-Eog Kim; Dong-Ick Shin; Wook-Joo Kim; Juneyoung Lee; Ji Sung Lee; Byung-Woo Yoon; Philip B Gorelick; Hee-Joon Bae
Journal:  Stroke       Date:  2015-08-04       Impact factor: 7.914

Review 8.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.

Authors:  Jonathan Emberson; Kennedy R Lees; Patrick Lyden; Lisa Blackwell; Gregory Albers; Erich Bluhmki; Thomas Brott; Geoff Cohen; Stephen Davis; Geoffrey Donnan; James Grotta; George Howard; Markku Kaste; Masatoshi Koga; Ruediger von Kummer; Maarten Lansberg; Richard I Lindley; Gordon Murray; Jean Marc Olivot; Mark Parsons; Barbara Tilley; Danilo Toni; Kazunori Toyoda; Nils Wahlgren; Joanna Wardlaw; William Whiteley; Gregory J del Zoppo; Colin Baigent; Peter Sandercock; Werner Hacke
Journal:  Lancet       Date:  2014-08-05       Impact factor: 79.321
  8 in total
  1 in total

1.  Effect of Intravenous Alteplase on Functional Outcome and Secondary Injury Volumes in Stroke Patients with Complete Endovascular Recanalization.

Authors:  Gabriel Broocks; Lukas Meyer; Celine Ruppert; Wolfgang Haupt; Tobias D Faizy; Noel Van Horn; Matthias Bechstein; Helge Kniep; Sarah Elsayed; Andre Kemmling; Ewgenia Barow; Jens Fiehler; Uta Hanning
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.